Guideline decision tool · Critical Care
🩸

Glucose Control in Critically Ill Patients — free guideline decision tool

Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.

Open guideline tool →
Computed locally — no data uploaded. For licensed clinicians.
📋

Guideline-based

Implements the decision logic from published clinical guidelines.

🖥️

Runs in your browser

No installation. Enter the patient's values and get a guideline recommendation instantly.

🔒

Data stays local

Nothing is uploaded. Results are for licensed clinicians only.

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

Current glucose200
Unitmg/dL
PopulationMost critically ill patients (target 140–180)

Glucose200 mg/dL

  • Glucose200 mg/dL (11.1 mmol/L)
  • Target rangeStandard 140–180 mg/dL (7.8–10.0 mmol/L)
  • Status / managementAbove target — ≥ 180 mg/dL (10 mmol/L): start/intensify IV insulin infusion, target 140–180 mg/dL
Current glucose200
Unitmmol/L
PopulationSelected populations — postop/cardiac/neuro (may be 110–140)

Glucose3600 mg/dL

  • Glucose3600 mg/dL (200 mmol/L)
  • Target rangeTighter 110–140 mg/dL (6.1–7.8 mmol/L)
  • Status / managementMarked hyperglycemia — Control with IV insulin infusion; investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers

Common questions

What is Glucose Control in Critically Ill Patients?

Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.

How is Glucose Control in Critically Ill Patients calculated? What is the core formula?

Target generally 140–180 mg/dL (7.8–10.0 mmol/L) for most critically ill; start IV insulin infusion when glucose is persistently > 180 mg/dL; avoid tight control (80–110) due to hypoglycemia harm; monitor frequently.

When is Glucose Control in Critically Ill Patients used?

Use in the ICU to select a blood-glucose target band and decide when to start IV insulin infusion, with attention to avoiding hypoglycemia.

What are the key clinical points for Glucose Control in Critically Ill Patients?

A moderate target (140–180 mg/dL) balances the harms of hyperglycemia against the hypoglycemia risk of tight control (original synthesis · not guideline verbatim). Tight glucose control (NICE-SUGAR) increased severe hypoglycemia and mortality, so it is no longer recommended. Frequent point-of-care monitoring and a validated infusion protocol reduce both hyper- and hypoglycemic excursions.

What are the limits and cautions when using Glucose Control in Critically Ill Patients?

For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.

How is Glucose Control in Critically Ill Patients calculated in practice? Can you show a worked example?

Inputs: Current glucose 200, Unit mg/dL, Population Most critically ill patients (target 140–180) → Result: Glucose 200 mg/dL(Glucose: 200 mg/dL (11.1 mmol/L), Target range: Standard 140–180 mg/dL (7.8–10.0 mmol/L), Status / management: Above target — ≥ 180 mg/dL (10 mmol/L): start/intensify IV insulin infusion, target 140–180 mg/dL) Inputs: Current glucose 200, Unit mmol/L, Population Selected populations — postop/cardiac/neuro (may be 110–140) → Result: Glucose 3600 mg/dL(Glucose: 3600 mg/dL (200 mmol/L), Target range: Tighter 110–140 mg/dL (6.1–7.8 mmol/L), Status / management: Marked hyperglycemia — Control with IV insulin infusion; investigate DKA/HHS, infection, steroids/parenteral nutrition and other triggers)

🩸

Run Glucose Control in Critically Ill Patients now

Glycemic targets and insulin-management direction for critically ill patients, avoiding both hyperglycemia and hypoglycemia.

Open guideline tool →

For licensed clinicians. Not a substitute for clinical judgement.

Share on XLinkedInWhatsAppEmail

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Related guideline tools

For use by licensed clinicians and clinical researchers. Computed locally in your browser — no data is uploaded. Not a substitute for clinical judgement.